文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

人类癌症中体细胞拷贝数改变的全景。

The landscape of somatic copy-number alteration across human cancers.

机构信息

Cancer Program and Medical and Population Genetics Group, The Broad Institute of M.I.T. and Harvard, 7 Cambridge Center.

出版信息

Nature. 2010 Feb 18;463(7283):899-905. doi: 10.1038/nature08822.


DOI:10.1038/nature08822
PMID:20164920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2826709/
Abstract

A powerful way to discover key genes with causal roles in oncogenesis is to identify genomic regions that undergo frequent alteration in human cancers. Here we present high-resolution analyses of somatic copy-number alterations (SCNAs) from 3,131 cancer specimens, belonging largely to 26 histological types. We identify 158 regions of focal SCNA that are altered at significant frequency across several cancer types, of which 122 cannot be explained by the presence of a known cancer target gene located within these regions. Several gene families are enriched among these regions of focal SCNA, including the BCL2 family of apoptosis regulators and the NF-kappaBeta pathway. We show that cancer cells containing amplifications surrounding the MCL1 and BCL2L1 anti-apoptotic genes depend on the expression of these genes for survival. Finally, we demonstrate that a large majority of SCNAs identified in individual cancer types are present in several cancer types.

摘要

发现与肿瘤发生有因果关系的关键基因的一种有力方法是鉴定在人类癌症中经常发生改变的基因组区域。在这里,我们呈现了来自 3131 个癌症标本的体细胞拷贝数改变(SCNAs)的高分辨率分析,这些标本主要属于 26 种组织学类型。我们鉴定了 158 个局灶性 SCNAs 区域,这些区域在几种癌症类型中发生改变的频率很高,其中 122 个不能用位于这些区域内的已知癌症靶基因的存在来解释。在这些局灶性 SCNAs 区域中富集了几个基因家族,包括凋亡调节剂 BCL2 家族和 NF-kappaBeta 途径。我们表明,含有围绕抗凋亡基因 MCL1 和 BCL2L1 的扩增的癌细胞依赖于这些基因的表达来存活。最后,我们证明在个体癌症类型中鉴定的大多数 SCNAs 存在于几种癌症类型中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3a/2826709/49836e67107b/nihms167245f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3a/2826709/472c1b6616de/nihms167245f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3a/2826709/c10fc3670339/nihms167245f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3a/2826709/68aa10da0a5a/nihms167245f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3a/2826709/49836e67107b/nihms167245f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3a/2826709/472c1b6616de/nihms167245f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3a/2826709/c10fc3670339/nihms167245f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3a/2826709/68aa10da0a5a/nihms167245f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f3a/2826709/49836e67107b/nihms167245f4.jpg

相似文献

[1]
The landscape of somatic copy-number alteration across human cancers.

Nature. 2010-2-18

[2]
Genomic analysis and selective small molecule inhibition identifies BCL-X(L) as a critical survival factor in a subset of colorectal cancer.

Mol Cancer. 2015-7-2

[3]
Breast cancer sub-types display heterogeneity in gene amplification and mRNA expression of the anti-apoptotic members of BCL2 family.

Gene. 2023-3-20

[4]
Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.

BMC Med Genomics. 2020-8-20

[5]
Key Survival Factor, Mcl-1, Correlates with Sensitivity to Combined Bcl-2/Bcl-xL Blockade.

Mol Cancer Res. 2017-3

[6]
Genomic determinants of somatic copy number alterations across human cancers.

Hum Mol Genet. 2016-3-1

[7]
Pan-cancer patterns of somatic copy number alteration.

Nat Genet. 2013-10

[8]
Anti-apoptotic protein BCL-XL as a therapeutic vulnerability in gastric cancer.

Animal Model Exp Med. 2023-6

[9]
GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers.

Genome Biol. 2011-4-28

[10]
NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells.

J Cell Physiol. 2021-11

引用本文的文献

[1]
Resistance to CDK7 inhibitors directed by acquired mutation of a conserved residue in cancer cells.

EMBO J. 2025-9-8

[2]
DDX27 in cancer: molecular mechanisms, clinical implications, and therapeutic potential.

J Transl Med. 2025-8-28

[3]
Evaluation of gene expression-based predictors of lymph node metastasis in bladder cancer.

Bladder Cancer. 2025-8-21

[4]
DelSIEVE: cell phylogeny modeling of single nucleotide variants and deletions from single-cell DNA sequencing data.

Genome Biol. 2025-8-25

[5]
Omics-Mediated Treatment for Advanced Prostate Cancer: Moving Towards Precision Oncology.

Int J Mol Sci. 2025-8-2

[6]
Low BOK Expression Promotes Epithelial-Mesenchymal Transition and Migration via the Wnt Signaling Pathway in Breast Cancer Cells.

Int J Mol Sci. 2025-7-27

[7]
From lab to life: technological innovations in transforming cancer metastasis detection and therapy.

Discov Oncol. 2025-8-10

[8]
MCL-1 as a molecular switch between myofibroblastic and pro-angiogenic features of breast cancer-associated fibroblasts.

Cell Death Dis. 2025-8-9

[9]
Tobacco smoke alters the trajectory of lung adenocarcinoma evolution via effects on somatic selection and epistasis.

bioRxiv. 2025-7-25

[10]
Integrative analysis of polyamine metabolism-related genes in gliomas: implications for prognosis and therapy.

Front Oncol. 2025-7-21

本文引用的文献

[1]
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1.

Nature. 2009-11-5

[2]
Identifying relationships among genomic disease regions: predicting genes at pathogenic SNP associations and rare deletions.

PLoS Genet. 2009-6

[3]
An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.

Oncogene. 2009-8-6

[4]
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells.

Cell. 2009-5-29

[5]
The cancer genome.

Nature. 2009-4-9

[6]
Linking somatic genetic alterations in cancer to therapeutics.

Curr Opin Cell Biol. 2009-4

[7]
MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family.

Oncogene. 2009-3-5

[8]
Highly parallel identification of essential genes in cancer cells.

Proc Natl Acad Sci U S A. 2008-12-23

[9]
Human embryonic stem cells reveal recurrent genomic instability at 20q11.21.

Nat Biotechnol. 2008-12

[10]
Recurrent chromosomal abnormalities in human embryonic stem cells.

Nat Biotechnol. 2008-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索